By Ventura Research Team 3 min Read
DRI Searches Two Locations; Cipla Share Price Decline
Share

Summary:

Cipla informed exchanges that the DRI searched its Vikhroli office and Bhiwandi depot over customs classification of an imported pharmaceutical product. The searches concluded on November 16 without reported material operational or financial impact, as shares declined amid mixed Q2FY27 performance.

Cipla Limited (NSE: CIPLA | BSE: 500087) has informed the stock exchange that the Directorate of Revenue Intelligence (DRI) conducted search proceedings at two premises of the company in Maharashtra on November 16, 2026.

The searches concerned the customs classification and exemption of an imported finished pharmaceutical product. The proceedings were concluded the same day, and Cipla said they had no material impact on its financial performance or operations.

DRI raids Bhiwandi depot, Vikhroli office

In a regulatory disclosure late on November 16, the DRI’s Mumbai zonal unit said searches were conducted at Cipla’s office in Vikhroli, Mumbai and its depot in Bhiwandi, Thane.

Action was taken under Section 105 of the Customs Act, 1962, which allows search of premises under certain circumstances.

The question is about the classification or the exemption that applies to a pharmaceutical finished product imported.

The product's customs classification is important because the category under which it is imported can affect the duty payable on import and whether it is eligible for exemptions.

Where a classification or exemption claim is wrong, there may be a dispute about the customs duty payable.

But a search proceeding does not by itself prove wrongdoing or ensure a duty demand or financial penalty will follow.

Cipla said it has provided cooperation and assistance to the authorities.

What Cipla Said About the Impact

"The company's announcement said:

DetailsParticulars
AuthorityDirectorate of Revenue Intelligence
Date searched16 Nov 2026
Location 1Vikhroli office in Mumbai
Location 2Bhiwandi depot, Thane
Applicable LawSection 105, Customs Act, 1962
SubjectClassification/exemption of imported pharmaceutical product
StatusSearch ended the same day
Material impactNo material impact reported by the company

The disclosure did not name the pharmaceutical product, quantify any disputed customs duty or state a financial penalty.

It also did not prove that the enforcement proceedings were finally determined.

Any future financial impact would be dependent on the result of the relevant examination and any further action thereafter.

Cipla Revenue declines 2% YoY in Q2FY27

The regulatory development comes on the back of Cipla posting its financial results for the September 2026 quarter.

Consolidated revenue from operations stood at ₹7,403.93 crore in Q2FY27 compared to ₹7,589.44 crore in Q2FY26, a fall of around 2.4% YoY.

However, the revenue improved 4% from ₹7,119.28 crore in Q1FY27.

The company reported EBITDA at about ₹ 1,388 crore with an EBITDA margin of 18.7%.

Profit after tax was about ₹878 crore against ₹1,351 crore in the corresponding quarter of last year.

That’s down around 35% YoY.

India business revenue up 12% YoY at ₹ 3,516 crore, North America revenue down 19% at ₹1,643 crore.

Domestic business growth was partially offset by weakness in overseas operations, with mixed regional performance.

Cipla Share Price Decline 

Shares of Cipla Limited witnessed a volatile trading session on Tuesday, November 17, 2026. The stock initially gained momentum and touched an intraday high of approximately ₹1,399 before facing selling pressure at higher levels. It subsequently slipped below ₹1,390 during the morning session and attempted a recovery around midday, but failed to sustain the gains. Selling pressure resurfaced in the afternoon, pushing the stock towards its intraday lows. As of 2:52 PM, Cipla was trading at ₹1,389.20, down ₹5.30 or 0.38%, indicating continued weakness despite intermittent recovery attempts.

What Lies Ahead for Cipla?

The big question now is whether the customs matter will lead to further proceedings, a demand for duties or any other formal measures.

Also, Cipla’s quarterly performance will be relevant, especially the divergence in growth between its Indian and North American business.

At this time, the company has indicated that the search was completed on November 16 with no material impact on operations or financials. The result of the underlying issue of customs classification has yet to be determined.

Please enter a valid name.

+91

Please enter a valid mobile number.

Enable WhatsApp notifications

Verify your mobile number

We have sent an OTP to +91 9876543210

The OTP you entered is invalid. Please try again.

0:60s

Resend OTP

Hold tight, we'll reach out to you the moment we're ready.
+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91